[
    [
        {
            "time": "2018-06-30",
            "original_text": "2018上半年医药制造行业概览：行业总体进入调整期 一致性评价进程提速",
            "features": {
                "keywords": [
                    "医药制造",
                    "调整期",
                    "一致性评价",
                    "进程提速"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2018上半年医药制造行业概览：行业总体进入调整期 一致性评价进程提速",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-07-15",
            "original_text": "嘉实事件驱动多只重仓股大跌，海归基金经理“水土不服”",
            "features": {
                "keywords": [
                    "嘉实事件驱动",
                    "重仓股大跌",
                    "海归基金经理",
                    "水土不服"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "嘉实事件驱动多只重仓股大跌，海归基金经理“水土不服”",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-08-20",
            "original_text": "医药周报2018第34期:关注结构性机会,看好创新药和生物类似药的发展",
            "features": {
                "keywords": [
                    "医药周报",
                    "结构性机会",
                    "创新药",
                    "生物类似药",
                    "发展"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药周报2018第34期:关注结构性机会,看好创新药和生物类似药的发展",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]